Passions

IPOs

Literature

Gator football

Experience

LB Pharmaceuticals Announces $285 Million Upsized IPO

September 12, 2025

Cooley advised LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases including schizophrenia, on its $285 million upsized initial public offering (IPO).

Read more

Related contacts

Brandon W. Fenn
Partner, New York
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Minkyu Park
Special Counsel, New York
Denny Xu
Associate, Boston
Danbi Kim
Associate, Boston
Ariane A. Andrade
Partner, Chicago
Nathaniel Hearn Jr.
Associate, Chicago
Karun Ahuja
Special Counsel, Chicago
Brandon Lefebvre
Quantitative Analyst, Boston
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Gerard O'Shea
Partner, New York
David Peinsipp
Partner, San Francisco
Ryan Vann
Partner, Chicago
Francis Wheeler
Senior Counsel, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Jessica Koffel
Special Counsel, Brussels
Rebecca Ross
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Chelsea Braun
Associate, Boston
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Vince Flynn
Associate, San Diego
Virat Gupta
Associate, Washington, DC
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Brenna McGuire
Associate, Washington, DC
Sarah Miller
Associate, New York
Jayne M. Munger
Associate, New York
Miles Patton
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Cathy Rude
Paralegal Specialist, Boston
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Cooley Advises Uber on $2.25 Billion Investment-Grade Bond Offering

September 8, 2025

Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, leading technology, operational excellence and product expertise to power movement from point A to point B, on its $2.25 billion investment-grade bond offering.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Matt Kong
Associate, San Francisco
Eric Blanchard
Partner, Boston
Carlos Ramirez
Partner, San Diego
Siana Lowrey
Of Counsel
David Peinsipp
Partner, San Francisco
Talya Kornitzer
Associate, New York
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Michael Pelle
Associate, New York
Francis Wheeler
Senior Counsel, Colorado
Jack Jones
Special Counsel, London
Helena Ferreira
Associate, Boston
Peter A. Haddad
Associate, San Diego
Jacob B. Hanna
Associate, San Francisco
Yoni Horn
Associate, Santa Monica
Xueqing Li
Associate, San Francisco
Marjorie O'Neill
Associate, San Francisco
Eric Steiner
Paralegal Specialist, San Francisco

Related Practices & Industries

Heartflow Announces $364.2 Million Upsized IPO

August 11, 2025

Cooley advised the underwriters of Heartflow, a leader in artificial intelligence technology for coronary artery disease, in connection with Heartflow’s $364.2 million upsized initial public offering.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Eric Greig
Partner, Washington, DC
Joanna Liebes Hubberts
Partner, San Diego
Dr. Madhuri Roy
Partner, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Barbara Mirza
Partner, Santa Monica
Xander Lee
Partner, Santa Monica
Jane Adams
Partner, San Diego
Annie Froehlich
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Francis Wheeler
Senior Counsel, Colorado
Jessica Koffel
Special Counsel, Brussels
Dillon Martinson
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Max Gonzalez
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Ryan Lewis
Associate, Colorado
Tyler Saavedra-Buckley
Associate, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles

Related Practices & Industries

Shoulder Innovations Announces $75 Million IPO

July 31, 2025

Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Scott Weston
Partner, Boston
Kassity L. Mai
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Valerie Sapozhnikova
Associate, Los Angeles
Alex Hammer
Associate, San Francisco
Allison Kutner
Associate, New York
Sunny J. Levine
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Uber Announces $1 Billion Exchangeable Senior Notes Offering

May 15, 2025

Cooley advised Uber Technologies (NYSE: UBER), a technology platform that uses a massive network, top technology, operational excellence and deep product knowledge to power movement from Point A to Point B, on its offering of $1 billion principal amount of 0% exchangeable senior notes due 2028.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Matt Kong
Associate, San Francisco
Carlos Ramirez
Partner, San Diego
Eric Blanchard
Partner, Boston
Siana Lowrey
Of Counsel
David Peinsipp
Partner, San Francisco
Jacob B. Hanna
Associate, San Francisco
Talya Kornitzer
Associate, New York
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Darren DeStefano
Partner, Reston
Shannon Eagan
Partner in Charge – Palo Alto, Palo Alto
Claire Keast-Butler
Co-Partner in Charge – London, London
Michael Neumeister
Partner, Los Angeles
Ellie Seber
Partner, Santa Monica

Related Practices & Industries

View more

David always has creative solutions for the more complex and bespoke issues. He has a reputation for being the go-to for answers to the hardest questions.

Chambers USA, 2024

David is the only partner I would use for an IPO or financing, he is that good.

Chambers USA, 2025

Admissions and credentials

California

Not admitted to practice in Florida

Rankings and accolades

Chambers USA: Band 1: Capital Markets: Debt & Equity: Western United States – Nationwide (2019 – 2025)

Chambers USA: Band 1: Capital Markets: Debt & Equity – California (2019 – 2025)

Chambers USA: SPACs – Nationwide (2023)

The Legal 500 US: Leading Lawyer in Capital Markets: Equity Offerings (2020 – 2025)

Daily Journal: California Lawyer Attorneys of the Year Awards (2020)

IFLR1000 US: Lawyer of the Year – Capital Markets (2020)

Daily Journal: Top 100 Lawyers in California (2019 – 2020)

Law 360: Capital Markets MVP (2019)

The Legal 500 US: Next Generation Lawyer in Capital Markets: Equity (2019)

Daily Journal: Top 20 Under 40 (2014)

Memberships and affiliations

American Bar Association (ABA)

The Bar Association of San Francisco

Representative issuers:

Dave has represented companies/investment banks on capital market transactions involving issuers across industries, such as: 10X Genomics, 4D Molecular Therapeutics, Accelerate Diagnostics, Acutus Medical, Aerohive Networks, Alteryx, ALX Oncology, Ambarella, Amyris, Applied Molecular Transport, Anthera Pharmaceuticals, Apigee, Applied Molecular Transport, Annexon, Apptio, Arcadia Biosciences, Arcutis Biotherapeutics, Aridis Pharmaceuticals, ARMO BioSciences, Ascendis Pharma, ASLAN Pharmaceuticals, Atlassian, Athira Pharma, Audentes Therapeutics, Cision, Crinetics Pharmaceuticals, Dermira, DocuSign, Doximity, Dutch Bros., EHang, Eidos Therapeutics, Expensify, Fantex, FIGS, FireEye, Five Prime Therapeutics, Global Blood Therapeutics, Gossamer Bio, Graphite Bio, Gritstone Oncology, Guardant Health, Health Catalyst, HealthEquity, Hyperion Therapeutics, IGM Biosciences, Ignyta, Immune Design, Inhibrx, Invitae, Kinnate Biopharma, Kodiak Sciences, LinkedIn, Livongo Health, Lulu’s Fashion Lounge, Lyell Immunopharma, MINDBODY, Mobile Iron, NantKwest, Nanthealth, NerdWallet, New Relic, Olema Pharmaceuticals, Ooma, Opendoor Labs, Otonomy, Pliant Therapeutics, Principia Biopharma, PROCEPT BioRobotics, ProNai, ProQR Therapeutics, PROS Holdings, Rigel Pharmaceuticals, Qualtrics, Root, Sana Biotechnology, Satsuma Pharmaceuticals, Savara, Shockwave Medical, Sierra Oncology, Smart Share Global, Snap, Stitch Fix, Sutro Biopharma, Sweetgreen, Syndax Pharmaceuticals, Tableau Software, Taiwan Liposome Company, Treace Medical Concepts, Tricida, Trivascular, Twilio, Uber, Ventyx, ViewRay, Warby Parker, Wish, Xenon Pharmaceuticals, Xometry, Yelp, Zendesk, Zscaler, Zymeworks, Zynga.